Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Disc Medicine, Inc.IRON · Entity 2273 | Chief Financial Officer | January 10, 2024 | March 02, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Disc Medicine, Inc.
Report date January 10, 2024 · Filed March 02, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,665 |
Reported balance
After 2024-01-10 transaction · row 1
1 source rowRow 1 · 2024-01-10 · Grant · Acquired 18,165 · Balance 23,665 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $63.90 · Expires 2034-01-09 | Direct | 27,250 |
Reported balance
After 2024-01-10 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-01-10 · Grant · Acquired 27,250 · Balance 27,250 F1: 25% of the shares underlying this option shall vest and become exercisable on January 10, 2025, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: 25% of the shares underlying this option shall vest and become exercisable on January 10, 2025, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 10, 2024 Filed Mar 2, 2024 00:49 UTC | Disc Medicine, Inc. IRON · Entity 2273 | GrantStock Option (Right to Buy) · Derivative | 27,250 | $0.00 Strike: $63.90 | $0.00 |
DisclosureSEC source: 0000950170-24-024210 · ownership.xml · derivative · entry 2 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,250 Underlying: Common Stock · 27,250 shares Expires 2034-01-09 F1 · derivative.exercise_date: 25% of the shares underlying this option shall vest and become exercisable on January 10, 2025, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| January 10, 2024 Filed Mar 2, 2024 00:49 UTC | Disc Medicine, Inc. IRON · Entity 2273 | GrantCommon Stock | 18,165 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024210 · ownership.xml · nonDerivative · entry 1 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,665 Read SEC document |
| December 27, 2023 Filed Dec 29, 2023 21:15 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $9.86 | $0.00 |
DisclosureSEC source: 0000950170-23-073844 · ownership.xml · derivative · entry 2 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,745 Underlying: Common Stock · 3,000 shares Expires 2031-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments following September 1, 2021, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| December 27, 2023 Filed Dec 29, 2023 21:15 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionCommon Stock | 3,000 | $9.86 | $29,580.00 |
DisclosureSEC source: 0000950170-23-073844 · ownership.xml · nonDerivative · entry 1 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 21:15 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0000950170-23-070394 · ownership.xml · derivative · entry 3 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,253 Underlying: Common Stock · 2,500 shares Expires 2030-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2023. F3 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments following January 1, 2020, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 21:15 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 2,500 | $65.22 | $163,061.50 |
DisclosureSEC source: 0000950170-23-070394 · ownership.xml · nonDerivative · entry 2 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,500 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.05 to $65.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 21:15 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionCommon Stock | 2,500 | $2.65 | $6,625.00 |
DisclosureSEC source: 0000950170-23-070394 · ownership.xml · nonDerivative · entry 1 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2023. Read SEC document |
| December 05, 2023 Filed Dec 7, 2023 21:15 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionStock Option (Right to Buy) · Derivative | 755 | $0.00 Strike: $1.01 | $0.00 |
DisclosureSEC source: 0000950170-23-068812 · ownership.xml · derivative · entry 7 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 752 Underlying: Common Stock · 755 shares Expires 2029-11-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2023. F5 · derivative.exercise_date: The shares underlying this option vest in 16 equal quarterly installments following May 1, 2020, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| December 05, 2023 Filed Dec 7, 2023 21:15 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionStock Option (Right to Buy) · Derivative | 526 | $0.00 Strike: $1.01 | $0.00 |
DisclosureSEC source: 0000950170-23-068812 · ownership.xml · derivative · entry 6 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 526 shares Expires 2029-11-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2023. F4 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof. Read SEC document |
| December 05, 2023 Filed Dec 7, 2023 21:15 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 100 | $57.06 | $5,706.00 |
DisclosureSEC source: 0000950170-23-068812 · ownership.xml · nonDerivative · entry 5 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,500 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2023. Read SEC document |
| December 05, 2023 Filed Dec 7, 2023 21:15 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 1,293 | $56.55 | $73,114.75 |
DisclosureSEC source: 0000950170-23-068812 · ownership.xml · nonDerivative · entry 4 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,600 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.05 to $57.04, inclusive. Read SEC document |
| December 05, 2023 Filed Dec 7, 2023 21:15 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 1,148 | $55.29 | $63,478.32 |
DisclosureSEC source: 0000950170-23-068812 · ownership.xml · nonDerivative · entry 3 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,893 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.93 to $55.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| December 05, 2023 Filed Dec 7, 2023 21:15 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionCommon Stock | 755 | $1.01 | $762.55 |
DisclosureSEC source: 0000950170-23-068812 · ownership.xml · nonDerivative · entry 2 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,041 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2023. Read SEC document |
| December 05, 2023 Filed Dec 7, 2023 21:15 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionCommon Stock | 526 | $1.01 | $531.26 |
DisclosureSEC source: 0000950170-23-068812 · ownership.xml · nonDerivative · entry 1 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2023. Read SEC document |
| September 11, 2023 Filed Sep 13, 2023 20:15 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $9.86 | $0.00 |
DisclosureSEC source: 0000950170-23-047933 · ownership.xml · derivative · entry 2 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,745 Underlying: Common Stock · 2,500 shares Expires 2031-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments following September 1, 2021, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| September 11, 2023 Filed Sep 13, 2023 20:15 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionCommon Stock | 2,500 | $9.86 | $24,650.00 |
DisclosureSEC source: 0000950170-23-047933 · ownership.xml · nonDerivative · entry 1 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,760 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 20:16 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0000950170-23-046397 · ownership.xml · derivative · entry 3 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,753 Underlying: Common Stock · 1,000 shares Expires 2030-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 15, 2023. F2 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments following October 7, 2020, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 20:16 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 1,000 | $52.99 | $52,990.00 |
DisclosureSEC source: 0000950170-23-046397 · ownership.xml · nonDerivative · entry 2 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,260 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 15, 2023. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 20:16 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionCommon Stock | 1,000 | $2.65 | $2,650.00 |
DisclosureSEC source: 0000950170-23-046397 · ownership.xml · nonDerivative · entry 1 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,260 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 15, 2023. Read SEC document |
| August 01, 2023 Filed Aug 3, 2023 20:18 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,521 | $0.00 Strike: $1.01 | $0.00 |
DisclosureSEC source: 0000950170-23-038027 · ownership.xml · derivative · entry 4 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,507 Underlying: Common Stock · 4,521 shares Expires 2029-11-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: he transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 15, 2023. F4 · derivative.exercise_date: The shares underlying this option vest in 16 equal quarterly installments following May 1, 2020, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| August 01, 2023 Filed Aug 3, 2023 20:18 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 1,454 | $50.50 | $73,420.31 |
DisclosureSEC source: 0000950170-23-038027 · ownership.xml · nonDerivative · entry 3 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,260 F1 · kind: he transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 15, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.15 to $50.85, inclusive. Read SEC document |
| August 01, 2023 Filed Aug 3, 2023 20:18 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 3,067 | $49.63 | $152,212.76 |
DisclosureSEC source: 0000950170-23-038027 · ownership.xml · nonDerivative · entry 2 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,714 F1 · kind: he transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 15, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.14 to $50.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| August 01, 2023 Filed Aug 3, 2023 20:18 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionCommon Stock | 4,521 | $1.01 | $4,566.21 |
DisclosureSEC source: 0000950170-23-038027 · ownership.xml · nonDerivative · entry 1 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,781 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: he transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 15, 2023. Read SEC document |
| June 28, 2023 Filed Jun 30, 2023 20:49 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,880 | $0.00 Strike: $1.01 | $0.00 |
DisclosureSEC source: 0000950170-23-031149 · ownership.xml · derivative · entry 5 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 526 Underlying: Common Stock · 7,880 shares Expires 2029-11-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 15, 2023. F5 · derivative.exercise_date: The shares underlying this option vest in 16 equal quarterly installments following September 13, 2019, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| June 28, 2023 Filed Jun 30, 2023 20:49 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 359 | $51.23 | $18,390.85 |
DisclosureSEC source: 0000950170-23-031149 · ownership.xml · nonDerivative · entry 4 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,260 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 15, 2023. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.20 to $51.28, inclusive. Read SEC document |
| June 28, 2023 Filed Jun 30, 2023 20:49 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 4,905 | $50.50 | $247,681.41 |
DisclosureSEC source: 0000950170-23-031149 · ownership.xml · nonDerivative · entry 3 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,619 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 15, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.87 to $50.76, inclusive. Read SEC document |
| June 28, 2023 Filed Jun 30, 2023 20:49 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 4,808 | $49.30 | $237,041.61 |
DisclosureSEC source: 0000950170-23-031149 · ownership.xml · nonDerivative · entry 2 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,524 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 15, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.80 to $49.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4. Read SEC document |
| June 28, 2023 Filed Jun 30, 2023 20:49 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionCommon Stock | 7,880 | $1.01 | $7,958.80 |
DisclosureSEC source: 0000950170-23-031149 · ownership.xml · nonDerivative · entry 1 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,332 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 15, 2023. Read SEC document |
| December 29, 2022 Filed Jan 3, 2023 22:05 UTC | Disc Medicine, Inc. IRON · Entity 2273 | GrantStock Option (Right to Buy) · Derivative | 33,847 | $0.00 Strike: $13.50 | $0.00 |
DisclosureSEC source: 0000899243-23-000299 · doc4.xml · derivative · entry 1 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,847 Underlying: Common Stock · 33,847 shares Expires 2032-12-28 F1 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments following December 29, 2022, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.